ACADIA PHARMACEUTICALS INC ($ACAD)
Filing Information
| Accession Number | 0001899977-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 7, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
60,423
Total Value
$946,557.45
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, CHIEF FINANCIAL OFFICER | Common Stock | โ | Aug 5, 2026 | Exercise/Conversion | 5,849 | $17.84 | $104,346.16 | 73,677 | Direct | โ | View Details | |
EVP, CHIEF FINANCIAL OFFICER | Common Stock | โ | Aug 5, 2026 | Sale | 5,849 | $29.00 | $169,637.96 | 67,828 | Direct | โ | View Details | |
EVP, CHIEF FINANCIAL OFFICER | Common Stock | โ | Aug 6, 2026 | Exercise/Conversion | 14,292 | $17.84 | $254,969.28 | 82,120 | Direct | โ | View Details | |
EVP, CHIEF FINANCIAL OFFICER | Common Stock | โ | Aug 6, 2026 | Sale | 5,000 | $29.00 | $145,000.00 | 77,120 | Direct | โ | View Details | |
EVP, CHIEF FINANCIAL OFFICER | Common Stock | โ | Aug 6, 2026 | Sale | 9,292 | $29.34 | $272,604.05 | 67,828 | Direct | โ | View Details | |
EVP, CHIEF FINANCIAL OFFICER | Stock Option (Right to Buy) | Derivative | Aug 5, 2026 | Exercise/Conversion | 5,849 | $0.00 | $0.00 | 74,715 | Direct | โ | View Details | |
EVP, CHIEF FINANCIAL OFFICER | Stock Option (Right to Buy) | Derivative | Aug 6, 2026 | Exercise/Conversion | 14,292 | $0.00 | $0.00 | 60,423 | Direct | โ | View Details |